tiprankstipranks
Trending News
More News >
Algernon Pharmaceuticals (TSE:AGN)
:AGN
Canadian Market

Algernon Pharmaceuticals (AGN) Cash flow

Compare
37 Followers

Algernon Pharmaceuticals Cash Flow

TSE:AGN's free cash flow for Q4 2025 was C$-489.06K. For the 2025 fiscal year, TSE:AGN's free cash flow was decreased by C$1.64M and operating cash flow was C$-489.06K. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
C$ -1.16MC$ -2.71MC$ -2.55MC$ -2.91MC$ -7.82M
Investing Cash Flow
C$ 150.03KC$ 2.28MC$ -59.50KC$ -144.61KC$ -124.45K
Financing Cash Flow
C$ 587.31KC$ 901.09KC$ 1.33MC$ 2.06MC$ 4.25M
End Cash Position
C$ 176.50KC$ 596.20KC$ 125.08KC$ 1.41MC$ 2.41M
Free Cash Flow
C$ -1.16MC$ -2.79MC$ -2.61MC$ -3.06MC$ -7.95M
Currency in CAD

Algernon Pharmaceuticals Cash Flow